Are epidural steroid injections effective for patients with moderate lumbar spinal canal stenosis?

Epidural Steroids for Moderate Lumbar Spinal Stenosis

Do not routinely offer epidural steroid injections for patients with moderate lumbar spinal stenosis, particularly if they present with predominantly axial (back) pain without significant radicular symptoms. The most recent and highest-quality evidence from the 2025 BMJ guideline provides a strong recommendation AGAINST epidural injections for chronic axial spine pain, stating that "all or nearly all well-informed people would likely not want such interventions" 1.

Critical Distinction: Radicular vs. Axial Pain

The effectiveness of epidural steroids in lumbar stenosis depends critically on the pain pattern:

If Predominantly Radicular Pain (Leg Pain/Neurogenic Claudication):

• Epidural steroid injections may provide short-term benefit only (≤3 months)
• The 2025 AAN systematic review found ESIs possibly reduce short-term disability (NNT 4) but do NOT significantly reduce short-term pain in lumbar stenosis 2
• Long-term disability reduction is possible (NNT 8), but long-term pain relief is uncertain 2
• The 2021 ASIPP guidelines provide a moderate-to-strong recommendation for fluoroscopically guided epidural injections in spinal stenosis 1

If Predominantly Axial Pain (Back Pain Without Significant Leg Symptoms):

• Strong recommendation AGAINST epidural injections 1
• The 2021 ACOEM guideline explicitly recommends against lumbar epidural injections for spinal stenosis "in the absence of significant radicular symptoms" 1
• The 2020 NICE guideline states: "Do not offer spinal injections for managing low back pain" 1

Guideline Controversy and Resolution

There is substantial disagreement among professional societies:

Supporting ESI:

• 2022 ASPN: Strong recommendation for epidural injections in spinal stenosis 1
• 2021 ASIPP: Moderate-to-strong recommendation 1

Against ESI:

• 2025 BMJ (most recent): Strong recommendation AGAINST for axial pain 1
• 2021 ACOEM: Recommended against without radicular symptoms 1
• 2020 NICE: Do not offer 1

The 2025 BMJ guideline should take precedence as the most recent, evidence-based (not consensus-based) guideline from a prestigious journal that explicitly evaluated patient values and preferences.

Stenosis Severity Matters

For moderate stenosis specifically:

• A 2026 meta-analysis found that pain relief was significantly weaker in patients with severe stenosis, and functionality improvements were limited in moderate/severe stenosis 3
• A 2014 study found no correlation between stenosis severity and response to epidural injection 4
• Patients with mild-to-moderate stenosis are more likely to experience positive results than those with severe stenosis 3

If You Proceed Despite Recommendations

Should you decide to offer ESI in moderate stenosis with radicular symptoms:

Technical Considerations:

• Steroid choice: Betamethasone provides the greatest and most prolonged relief, even at low doses 3
• Triamcinolone and methylprednisolone offer similar initial relief but decrease more rapidly 3
• Dexamethasone is least effective 3
• Route: Transforaminal, interlaminar, or caudal routes show no significant outcome differences 3
  • Transforaminal preferred for single-level stenosis
  • Interlaminar or caudal for multilevel pathology 3
• Fluoroscopic or ultrasound guidance recommended 1, 5

Expected Outcomes:

• Most studies report significant pain relief up to 3 months 3
• Some report persistence beyond one year 3
• Short-term effectiveness demonstrated in multiple studies 4, 5
• Caution: One SPORT subgroup analysis found ESIs associated with LESS improvement at 4 years, longer operative times if surgery eventually needed, and increased crossover rates between treatment groups 6

Safety Concerns

Do not minimize the risks:

• Small risk of moderate-to-serious harms: deep infection, temporary altered consciousness 1
• Very small risk of catastrophic harms: paralysis and death 1
• Patients must weigh these risks against modest, primarily short-term benefits

Clinical Algorithm

1. Determine pain pattern:

   • Predominantly axial back pain → Do not offer ESI
   • Significant radicular leg pain/neurogenic claudication → Consider ESI only for short-term relief

2. Assess stenosis severity:

   • Severe stenosis → Lower likelihood of benefit
   • Mild-to-moderate stenosis with radicular symptoms → May consider

3. Set realistic expectations:

   • Likely benefit limited to ≤3 months
   • May reduce disability more than pain
   • Long-term pain relief uncertain

4. If proceeding:

   • Use betamethasone (most effective steroid)
   • Fluoroscopic guidance
   • Maximum 4 injections to assess response
   • Plan alternative treatment if no response after 4 injections 5

The evidence strongly suggests that for moderate lumbar stenosis, particularly with axial pain predominance, epidural steroids should not be offered outside of clinical trials, given the limited benefits, potential harms, and patient preference data indicating most well-informed patients would decline this intervention 1.